The Federal Trade Commission’s May 1, 2026 consent order involving “micromarket kiosk” companies illustrates how the agency ...
The Federal Trade Commission has reached a landmark settlement with Express Scripts, addressing allegations that the pharmacy benefit manager inflated drug prices, including for insulin, to boost ...
The Federal Trade Commission has reached a landmark settlement with Express Scripts, banning practices that favored high-priced drugs for bigger rebates and requiring lower-cost options be included in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results